Biological
Naser Al-Husban
Naser Al-Husban is a biological therapy with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completed
COVID-19 Vaccines and the Menstrual Cycle
NCT05688995
completed
Postpartum Depression
NCT05595512
completed
Hysteroscopic Surgery; Retrospective Cross-sectional Study of Reproductive Outcome
NCT05560295
completed
SLE Therapy Changes in Pregnancy and Relation to Pregnancy Outcome
NCT05176041
completed
COVID-19 Pandemic and Medical Students
NCT04726865
Clinical Trials (5)
Showing 5 of 5 trials
NCT05688995
COVID-19 Vaccines and the Menstrual Cycle
NCT05595512
Postpartum Depression
NCT05560295
Hysteroscopic Surgery; Retrospective Cross-sectional Study of Reproductive Outcome
NCT05176041
SLE Therapy Changes in Pregnancy and Relation to Pregnancy Outcome
NCT04726865
COVID-19 Pandemic and Medical Students
All 5 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 5